February 3 - 7, 2024

Boston, MA, USA

Transform Drug Discovery with Cutting-Edge SPR and Mass Spec at SLAS2024!

Register for SLAS2024 today to experience the latest advancements in Surface Plasmon Resonance (SPR) technology and Mass-Spectrometry (MS) based High-Throughput Screening (HTS) with timsTOF MALDI PharmaPulse®. Accelerate your research journey with the tools trusted by leading researchers and pharmaceutical companies worldwide.

Event Highlights

  • Meet us at Booth 836: We're looking forward to meeting you in front of our SPR and MS based solutions that will be on display at our booth. Take the chance to discuss with our experts how SPR and mass spectrometry can help you in current and future projects.
  • Exhibitor tutorials on SPR and Mass Spec applications: Attend our tutorial sessions hosted by Bruker's expert team to discover the latest on SPR and mass spec applications.

Bruker Exhibitor Tutorial: Monday, February 5, 2024
12:00 - 1:00 pm EST

Location: Room 152

Innovation to do More - Discover the all new SPR #64

The Bruker SPR Pro Series instruments are essential tools for achieving optimal performance without compromising on flexibility and throughput. Thus, the Bruker SPR-24 Pro and the Bruker SPR-32 Pro have established themselves as reputable SPR instruments in both the pharmaceutical industry as well as academic research organizations. These instruments exhibit remarkable flexibility by allowing the individual spot addressing thus enabling a wide range of applications, from small molecules to biologics and spanning thermodynamic analysis, kinetic measurements, and epitope binning experiments. In this tutorial, we present Bruker’s latest advancement in SPR instruments, featuring an innovative 8-channel multi-spot addressing fluidic design and an exceptional detector, combined with a high-throughput autosampler, as well as automation capabilities - enabling scientists to conduct their work without any concessions. This new and unique instrument allows for the analysis of all types of samples, in a high throughput fashion as well as the possibility of in-depth assay development.

Sven Malik, Senior Application Scientist SPR, Bruker Daltonics SPR, Hamburg, Germany

Sven studied Bioprocess Engineering at the Technical University of Dresden, Germany, and graduated in 2012. During his diploma studies, he investigated the interaction of cytomegalovirus protein pp65 against certain antibodies using Surface Plasmon Resonance. In 2012 he joined Sierra Sensors GmbH to start his role as an application specialist. After 6 years he became a senior application specialist as Bruker acquired Sierra Sensors GmbH. Currently he is involved in customer support and product development.

Cyrill Brunner, Ph.D., Senior Application Scientist, Bruker Switzerland, Fällanden, Switzerland

Dr. Cyrill Brunner is a trained pharmacist and obtained his Ph.D. at ETH Zurich in the group of Prof. Gisbert Schneider. His main background is numerous biophysical assays including SPR and computational drug design. He joined Bruker as an application specialist in April 2020 and heads the SPR application lab in Fällanden, Switzerland.

David Myszka, Ph.D., Director Biosensor Tools LLC, Salt Lake City, UT, USA

David got a Ph.D. in Biochemistry in 1991. He's worked on applications development and analysis tools for label-free biosensors for the past 30 years. He's authored over 160 publications related to the analysis of molecular interactions. David is an expert in the field of Surface Plasmon Resonance. With his company Biosensor Tools, he is providing biosensor-related services from assay development and screening to kinetics and biosimilar analysis and servicing label-free instruments from all vendors.

Bruker Exhibitor Tutorial: Tuesday, February 6, 2024
2:00 - 3:00 pm EST

Location: Room 152

Accelerating drug discovery & development with high-throughput mass spec solutions powered by timsTOF technology

timsTOF MALDI PharmaPulse® (MPP) achieves unprecedented levels of performance in label-free uHTS/HTE combining proven MALDI speed and robustness with unparalleled assay specificity and sensitivity enabled by timsTOF technology. When integrated with automated high-throughput MALDI sample prep, for example using the Analytik Jena CyBio Well Vario 1536 liquid handling platform, timsTOF MPP provides end-to-end workflow support for a wide range of uHTS/HTE applications including cellular assays, AS-MS based protein-ligand interaction screening and medchem synthetic chemistry HTE.

Discover Bruker's high-throughput mass-spec biopharma solutions:

  • Protein degradation, HCP analysis, and immunopeptidomics taking advantage of Bruker's 4D-Proteomics™ Ecosystem
  • Enhanced characterization of biologics with automated high-throughput sample prep using the Integrated Protein Technologies SampleStream™ platform
  • Bruker OligoQuest™: Cutting-edge software for in-depth characterization of DNA, RNA & beyond

Arndt Asperger, Ph.D., Senior Applications Scientist, High Throughput Screening MALDI Mass Spectrometry, Bruker Daltonics, Bremen, Germany

Arndt Asperger is analytical chemist by training and got his Ph.D. from Leipzig University in Germany. He joined Bruker in 2002 and has been working in various positions related to MALDI-MS applications and applications development. His current focus is on applications development of pharma and biopharma related high-throughput mass spectrometry methods.

Christian Klinner, Ph.D., Application Specialist Liquid Handling and Automation Life Science Solutions, Analytik Jena GmbH & Co. KG, Jena, Germany

Christian Klinner, Ph.D., is biochemist by training. He is working at Analytik Jena GmbH & Co. KG, Jena, Germany, as an application specialist liquid handling & automation. In his current position, Christian provides applicative support to customers for liquid handling devices that are part of Analytik Jena´s life science solutions.

Be Part of the Future

Visit Booth 836 to learn more about our new SPR instrument and the MALDI PharmaPulse® mass spectrometer. Register for the Bruker Exhibitor Tutorial today to learn how to use Bruker technology to solve your specific research challenges.

Analytik Jena
Monday, February 5, 2024
2:00 - 3:00 pm EST

Location: Room 102A

High throughput mass spectrometry drug discovery screening powered by automated sample preparation through simultaneous 1536 well pipetting

Analytik Jena and collaboration partner Bruker built a bridge between the powerful and unique label free detection capabilities of mass spectrometry and modular automated uHTS sample preparation. With the pipetting device CyBio Well vario Analytik Jena offers a MALDI spotting and sample optimization which works in concert with Bruker MS solutions and therefore overcomes application specific bottlenecks. From basic automation concepts reaching from stand-alone medium troughgput MALDI sample preparation workstations, modules for integrators up to automation solutions covering the whole MALDI workflow for high and ultra-high troughput, Analytik jena offers a smart and modular solution inlcuding sample preparation, labware handling, and third-party device integration. The highly sophisticated GUI-based software solution CyBio MALDI Studio serves as a convenient software control that allows easy and flexible workstation management.

Biodesix has integrated Analytik Jena’s FeliX Liquid Handler, CyBio Carry, and Active Drier to execute MALDI-TOF mass spectrometry sample preparation.

Christian Klinner, Ph.D., Application Specialist Liquid Handling and Automation Life Science Solutions, Analytik Jena GmbH & Co. KG, Jena, Germany

Arndt Asperger, Ph.D., Senior Applications Scientist, High Throughput Screening MALDI Mass Spectrometry, Bruker Daltonics, Bremen, Germany

Amanda Weaver, Senior Scientist in Applied Research and Technology Biodesix, Inc., CO, USA

Kahler Pascuale Bugtong, Senior Automation Engineer, Aether Biomachines, Menlo Park, CA, USA

Bruker Cellular Analysis

Bruker Cellular Analysis is uniquely enabling the exploration of the phenome and mastery of single cells for all labs and scientists through a simple and accessible workflow.


As you are certainly aware, special compliance regulations apply to public officials* and healthcare professionals** with regard to the event we are planning. If you accept our invitation, we will therefore assume that you will observe the compliance regulations that apply to you and that you have the necessary employer approval.

*Government Official means according the Bruker policies any of the following: any officer, employee or representative of a government (national, regional or local) entity, or any public agency, public authority, department or instrumentality thereof, regardless of their rank or title (e.g. a regulatory official or government inspector); any person working for or advising a government-owned or government-controlled enterprise (e.g. a professor at a government-owned university, or a purchaser at a government-owned hospital); any person working for or advising a national or international non-governmental organization (e.g. an employee of the Red Cross or The World Bank); any person performing a public function or providing a public service, even if that person works for a non-governmental institution (e.g. private security personnel working in public functions); any person hired to review or accept bids for a government agency; any person with the responsibility to allocate or expend government funds; any person in a public law function, civil servant, judge or military personnel; any person acting for a political party, including party officials, candidates or individuals holding a position in a political party office; members of royal families; or immediate family members of any of the persons listed above. An immediate family member is a grandparent, parent, spouse, significant other, child, or sibling.

**A Healthcare Professional (HCP) is in accordance with the Bruker policies any physician, dentist, nurse, pharmacist or other individual who may prescribe, administer, purchase, dispense, recommend, or supply medical products or treatments or pharmaceutical products. In many cases, Bruker interacts with HCPs who work for state-owned hospitals (e.g. as medical scientists). These individuals will be classified as both HCPs and Government Officials.


For Research Use Only. Not for use in clinical diagnostic procedures.